Absolute risk of cardiovascular disease events, and blood pressure‐ and lipid‐lowering therapy in Australia
Authors:
- 2 May 2016
- journal article
- research article
- Published by Wiley in Medical Journal of Australia
- Vol. 204 (8) , 320
Abstract
An estimated 970 000 Australians may not be receiving recommended combination blood pressure- and lipid-lowering therapyKeywords
Funding Information
- National Health and Medical Research Council (1042717)
This publication has 20 references indexed in Scilit:
- Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient dataThe Lancet, 2014
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskCirculation, 2014
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)Heart, 2014
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART studyEuropean Journal of Preventive Cardiology, 2011
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular riskThe Lancet, 2005
- An updated coronary risk profile. A statement for health professionals.Circulation, 1991